Induction of labour using prostaglandin E2 as an inpatient versus balloon catheter as an outpatient: a multi-centre randomised controlled trial.
To compare clinical outcomes following induction of labour (IOL) using a balloon catheter and going home, versus prostaglandin (PG) as an inpatient. Randomised controlled trial. Eight Australian maternity hospitals. Women with uncomplicated term singleton pregnancies undergoing IOL for low-risk indications including post-term, advanced maternal age, 'social' reasons. Between September 2015 and October 2018, 347 women were randomised to a balloon outpatient and 348 to a PG inpatient group. PG group received Dinoprostone, either 2mg gel or 10mg controlled-release tape. Balloon group had a double-balloon catheter inserted and went home. The primary outcome was a composite neonatal measure comprising nursery admission, intubation/cardiac compressions, acidemia, hypoxic ischaemic encephalopathy, seizure, infection, pulmonary hypertension, stillbirth or death. Clinical and process outcomes are reported. There were no statistically significant differences in the primary outcome comparing balloon with PG (18.6% vs 25.8%; RR=0.77, 95% CI 0.51-1.02; p=0.070), cord arterial pH<7.10 (3.5% vs 9.2%; p=0.072), nursery admissions (12.6% vs 15.5%; p=0.379), neonatal antibiotic use (12.1% vs 17.6%; p=0.103), or mode of birth. Nulliparous women in the balloon group had lower rates of the primary outcome (20.4% vs 31.0%;p=0.032); Parous women were less likely to have an unassisted vaginal birth (77.6% vs 92.3%; p=0.045). Balloon catheters may be a superior method of cervical priming for nulliparous women, whereas this may not be the case for parous women. It is feasible that nulliparous women go home after commencing balloon catheter IOL, and the likelihood of adverse outcomes is low.